Genotoxic and carcinogenic effects of gastrointestinal drugs

Mutagenesis

Volumn 25, Issue 4, 2010, Pages 315-326

  Brambilla, Giovanni ^a   Mattioli, Francesca ^a   Martelli, Antonietta ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE EMODIN; ALOSETRON; ALUMINUM HYDROXIDE; BALSALAZIDE; BISACODYL; CIMETIDINE; CISAPRIDE; DANTRON; DRONABINOL; ESOMEPRAZOLE; FAMOTIDINE; GASTROINTESTINAL AGENT; GLYCYRRHETINIC ACID; IRSOGLADINE MALEATE; LANSOPRAZOLE; LUBIPROSTONE; MESALAZINE; METOCLOPRAMIDE; NIZATIDINE; OLSALAZINE; OMEPRAZOLE; PANTOPRAZOLE; PHENOLPHTHALEIN; PROPANTHELINE BROMIDE; RABEPRAZOLE; RANITIDINE; SALAZOSULFAPYRIDINE; SCOPOLAMINE; TEGASEROD; UNINDEXED DRUG; CARCINOGEN; MUTAGENIC AGENT;

CARCINOGENESIS; CARCINOGENICITY; COMPETITIVE INHIBITION; DRUG CYTOTOXICITY; DRUG EFFECT; GENE MUTATION; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TOXICITY TESTING; CARCINOGEN TESTING; CELL TRANSFORMATION; CHEMICALLY INDUCED; DRUG EFFECTS; MUTAGEN TESTING; NEOPLASM; PRODUCT SAFETY; RISK ASSESSMENT; TOXICITY;

CARCINOGENICITY TESTS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CONSUMER PRODUCT SAFETY; GASTROINTESTINAL AGENTS; HUMANS; MUTAGENICITY TESTS; MUTAGENS; NEOPLASMS; RISK ASSESSMENT;

EID: 77954450581     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geq025     Document Type: Review

References (67)

1. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). (1996) Guideline for Industry. S2A. Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals
2. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). (1997) Guidance for Industry. S2B. Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals.
3. Müller, L., Kikuchi, Y., Probst, G., Schechtman, L., Shimada, H., Sofuni, T. and Tweats, D. (1999) ICH-harmonized guidance on genotoxicity testing of pharmaceuticals; evolution, reasoning and impact. Mutat. Res., 436, 195-225 (Pubitemid 29246090)
4. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1996) Guidelines for Industry. S1A. The Need for Long-term Rodent Carcinoge-nicity Studies of Pharmaceuticals
5. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1997) Guidance for Industry. S1B. Testing for Carcinogenicity of Pharmaceuticals.
6. Sweetman, S.C. (ed.) (2007) Martindale. The Complete Drug Reference. 35th edn. Pharmaceutical Press, London, pp. 1526-1602.
7. Snyder, R. D. and Green, J. W. (2001) A review of the genotoxicity of marketed pharmaceuticals. Mutat. Res., 488, 151-169.
8. International Agency for Research on Cancer. (1972-2007) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.1-91. IARC, Lyon, France.
9. U.S. Department of Health and Human Sciences. (1988) Registry of Toxic Effects of Chemical Substances, 1985-1986. Washington, DC: National Institute for Occupational Safety and Health. 10. (2005) Physicians' Desk Reference. 59th edn. Thomson PDR, Montvale, NJ.
10. Westendorf, J., Marquardt, H., Poginski, B., Dominiak, M., Schmidt, J. and Marquardt, H. (1990) Genotoxicity of naturally occurring hydroxyanthra-quinones. Mutat. Res., 240, 1-12.
11. Sandnes, D., Johansen, T., Teien, G. and Ulsaker, G. (1992) Mutagenicity of crude senna and senna glycosides in Salmonella typhimurium. Toxicology, 71, 165-172.
12. Kawasaki, Y., Goda, Y. and Yoshihira, K. (1992) The mutagenic constituents of rubia tinctorum. Chem. Pharm. Bull., 40, 1504-1509.
13. Heidemann, A., Miltenburger, H. G. and Mengs, U. (1993) The genotoxicity status of senna. Pharmacology, 47 (Suppl. 1), 178-186. (Pubitemid 23291030)
14. (Pubitemid 26099865)
15. Heidemann, A., Voelkner, W. and Mengs, U. (1996) Genotoxicity of aloeemodin in vitro and in vivo. Mutat. Res., 367, 123-133. (Pubitemid 26099865)
16. U.S. National Library of Medicine\Toxnet, Toxicology Data Network. http://www.toxnet.nlm.nih.gov.
17. FDA, Center for Drug Evaluation and Research. http://www.fda.cder.
18. Stoll, R. E., Blanchard, K. T., Stoltz, J. H., Majerka, J. B., Furst, S., Lilly, P. D. and Mennear, J. H. (2006) Phenolphthalein and bisacodyl: assessment of genotoxic and carcinogenic responses in heterozygous p53 (\+/-) mice and Syrian hamster embryo (SHE) assay. Toxicol. Sci., 90, 440-450.
19. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., Mortelmans, K. and Speck, W. (1987) Salmonella mutagenicity tests. Part III: results from the testing of 255 chemicals. Environ. Mol. Mutagen., 9 (Suppl. 9), 1-110. (Pubitemid 17115119)
20. International Agency for Research on Cancer (1990) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.50. Pharmaceutical Drugs, IARC, Lyon, France.
21. Loveday, K. S., Lugo, M. H., Resnick, M. A., Anderson, B. E. and Zeiger, E. (1989) Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro: II. Results with 20 chemicals. Envron. Mol. Mutagen., 13, 60-94 (Pubitemid 19252658)
22. The Carcinogenic Potency Database. http://potency.berkeley.edu.
23. Tikkanen, L., Matsushima, T. and Natori, S. (1983) Mutagenicity of anthraquinones in the Salmonella preincubation test. Mutat. Res., 116, 297-304. (Pubitemid 13184879)
24. Krivobok, S., Seigle-Murandi, F., Steiman, R., Marzin, D. R. and Bettina, V. (1992) Mutagenicity of substituted anthraquinones in the Ames/Salmonella microsome system. Mutat. Res., 279, 1-8.
25. Kier, L. E., Brusick, D. J., Auletta, A. E. et al. (1986) The Salmonella typhimurium/mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 168, 69-240.
26. Mueller, O., Eckart, I., Lutz, W. K. and Stopper, H. (1996) Genotoxicity of the laxative drug components emodin, aloe-emodin, and danthron in mammalian cells: topoisomerase mediated? Mutat. Res., 371, 165-173. (Pubitemid 27036279)
27. Mori, H., Kawai, K., Ohbayashi, F., Kuniyasu, T., Yamazaki, M., Hamasaki, T. and Williams, G. M. (1984) Genotoxicity of a variety od mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes. Cancer Res., 44, 2918-2923. (Pubitemid 14083209)
28. Mueller, S. O., Lutz, W. K. and Stopper, H. (1998) Factors affecting the genotoxic potency ranking of natural anthraquinones in mammalian cell culture systems. Mutat. Res., 414, 125-129. (Pubitemid 28284946)
29. Mori, H., Sugie, S., Niwa, K., Yoshimi, N., Tanaka, T. and Hirono, I. (1986) Carcinogenicity of chrysazin in large intestine and liver of mice. Jap. J. Cancer Res. (GANN), 77, 871-876. (Pubitemid 16006780)
30. (1996) NCI/NTP Carcinogenesis Technical Report Series. National Cancer Institute/National Toxicology Program. U.S. Department of Health and Human Services. TR-446.
31. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T. and Mortelmans, K. (1988) Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ. Mol. Mutagen., 11 (Suppl. 12), 1-158. (Pubitemid 16084504)
32. (1996) Toxicology and carcinogenesis studies of 1-trans-delta-9-tetrahy- drocannabinol in F344 rats and B6C3F1 mice (gavage studies). Technical Report Series no. 446. NUIHB publication no. 97-3362. U.S. Department of Health and Human Services, National Toxicology Program. National Institute of Environmental Health Sciences, Research Triangle Park, NC.
33. Latt, S. A., Allen, J. and Bloom, S. E. (1981) Sister chromatid exchanges: a report of the Gene-Tox Program. Mutat. Res., 87, 17-62. (Pubitemid 11042443)
34. Heidelberger, C., Freeman, A. E., Pienta, R. J. et al. (1983) Cell transformation by chemical agents\a review ad analysis of the literature. Mutat. Res., 114, 283-385.
35. Mavournin, K. E., Blakey, D. H., Cimino, M. C., Salamone, M. F. and Heddle, J. A. (1990) The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 239, 29-80. (Pubitemid 20209463)
36. Wyrobek, A. J., Gordon, L. A., Burkhart, J. G., Francis, M. W., Kapp, R. W., Jr., Letz, G., Malling, H. V., Topham, J. C. and Whorton, M. D. (1983) An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 115, 1-72. (Pubitemid 13122041)
37. National Toxicology Program. (1997) Toxicology and carcinogenesis studies of scopolamine hydrobromide trihydrate in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol. Progr. Tech. Rep. Ser., 445.
38. Snyder, R. D., Ewing, D. and Hendry, L. B. (2006) DNA intercalative potential of marketed drugs testing positive in in vitro assays. Mutat. Res., 609, 47-59. (Pubitemid 44311611)
39. Nagasawa, Y., Miwa, Y., Hongyo, T., Sugawara, M. and Kawase, S. (1994) Mutagenicity study of mesalazine. Oyo Yakuri, 48, 501-509.
40. Loveday, K. S., Anderson, B. E., Resnick, M. A. and Zeiger, E. (1990) Chromosome aberration and sister chromatid exchange test in Chinese hamster ovary cells in vitro. Part V: results with 46 chemicals. Environ. Mol. Mutagen., 16, 272-303. (Pubitemid 19245677)
41. Martelli, A., Brambilla Campart, G., Canonero, R., Mattioli, F. and Brambilla, G. (1995) Testing of metoclopramide and procainamide for their ability to induce genotoxic effects in cultured mammalian cells. Toxicol. Appl. Pharmacol., 131, 185-191.
42. Mereto, E., Robbiano, L., Ghia, M., Allavena, A., Martelli, A. and Brambilla, G. (1995) Evaluation of DNA-damaging, clastogenic, and promoting activity of metoclopramide and procainamide in rats. Toxicol. Appl. Pharmacol., 131, 192-197.
43. Martelli, A., Mattioli, F., Mereto, E., Brambilla Campart, G., Sini, D., Bergamaschi, G. and Brambilla, G. (1998) Evaluation of omeprazole genotoxicity in a battery of in vitro and in vivo assays. Toxicology, 130, 29-41. (Pubitemid 28488573)
44. Crofton-Sleigh, C., Doherty, A., Ellard, S., Parry, E. M. and Venit, S. (1993) Micronucleus assay using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochrome P-450 and microsomal epoxide hydrolase. Mutagenesis, 8, 363-372. (Pubitemid 23226781)
45. Mereto, E., Ghia, M., Martelli, A. and Brambilla, G. (1993) Lack of evidence of omeprazole genotoxicity in Sprague-Dawley rats. Mutagenesis, 8, 379-386 (Pubitemid 23273979)
46. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. (2000). Some Antiviral and Antineoplastic Drugs and Other Pharmaceutical Agents. Vol.76. IARC, Lyon, France.
47. Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B. and Zeiger, E. (1986) Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mutagen., 8 (Suppl. 7), 1-119. (Pubitemid 16084504)
48. Galloway, S. M., Armstrong, M. J., Reuben, C. et al. (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluation of 108 chemicals. Environ. Mol. Mutagen., 10 (Suppl. 10), 1-175. (Pubitemid 18039247)
49. Valencia, R., Abrahamson, S., Lee, W. R., Von Halle, E. S., Woodruff, R. C., Wuergler, F. E. and Zimmering, S. (1984) Chromosome mutation tests for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 134, 61-88. (Pubitemid 14097629)
50. Okumura, K., Morita, T., Nagaki, T., Watanabe, Y. and Tsuji, H. (1984) Mutagenicity tests of ranitidine hydrochloride. Oyo Yakuri, 28, 163-169. (Pubitemid 14067234)
51. De Flora, S., Bennicelli, C., Camoirano, A. and Zanacchi, P. (1983) Genotoxicity of nitrosated ranitidine. Carcinogenesis, 4, 255-260. (Pubitemid 13091939)
52. Maura, A., Pino, A., Robbiano, L., Cajelli, E., Finollo, R., Cavanna, M. and Brambilla, G. (1983) DNA damage induced by nitrosated ranitidine in cultured mammalian cells. Toxicol. Lett., 18, 97-102. (Pubitemid 13048000)
53. Martelli, A., Fugassa, E., Voci, A. and Brambilla, G. (1983) Unscheduled DNA synthesis induced by nitrosated ranitidine in primary cultures of rat hepatocytes. Mutat. Res., 122, 373-376. (Pubitemid 14219255)
54. Brambilla, G., Cavanna, M., Faggin, P., Maura, A., Pino, A., Ricci, R. and Robbiano, L. (1983) Genotoxic effects in rodents given high oral doses of ranitidine and sodium nitrite. Carcinogenesis, 4, 1281-1285. (Pubitemid 14229456)
55. Iatropoulos, M. J., Williams, G. M., Abdo, K. M., Kari, F. W. and Hart, R. W. (1997) Mechanistic studies on genotoxicity and carcinogenicity of salicylazosulfapyridine an anti-inflammatory medicine. Exp. Toxicol. Pathol., 49, 15-28.
56. National Toxicology Program (1997) Toxicology and carcinogenesis studies of salicylazosulfapyridine (CAS No. 599-79-1) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol. Program Tech. Rep. Ser., 457.
57. Ishidate, M., Jr., Harnois, M. C. and Sofuni, T. (1988) A comprehensive analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat. Res., 195, 151-213. (Pubitemid 18066068)
58. Brambilla, G. and Martelli, A. (2009) Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics. Pharmacol. Res., 60, 1-17.
59. Brambilla, G., Carrozzino, R. and Martelli, A. (2007) Genotoxicity and carcinogenicity studies of benzodiazepines. Pharmacol. Res., 56, 443-458. (Pubitemid 350137767)
60. Tennant, R. W., Margolin, B. H., Shelby, M. D. et al. (1987) A comprehensive analysis of data on the clastogenicity genesis in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
61. Zeiger, E., Haseman, J. K., Shelby, M. D., Margolin, B. H. and Tennant, R. W. (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen., 16 (Suppl. 18), 1-14. (Pubitemid 20376833)
62. Kirkland, D. J., Aardema, M., Henderson, L. and Muller, L. (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res., 584, 1-256. (Pubitemid 40922793)
63. th IWGT, San Francisco, 9-10 September 2005. Mutat. Res., 627, 5-9.
64. Thybaud, V., Aardema, M., Clements, J. et al. (2007) Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Mutat. Res., 627, 41-58. (Pubitemid 46091766)
65. Tweats, D. J., Blakey, D., Heflich, R. H. et al. (2007) Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutat. Res., 627, 78-91. (Pubitemid 46098931)
66. International Agency for Research on Cancer. (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7. Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs, Vol.1-42. IARC, Lyon, France.
67. Brambilla, G. and Martelli, A. (2007) Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products. Mutat. Res., 635, 17-52. (Pubitemid 46482377)